Quick Answer
TherapeuticsMD, Inc. reported R&D Expense of $7.09 million for fiscal year 2021.
TherapeuticsMD, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2021 | $7.09M | -32.1% |
| 2020 | $10.43M | -47.3% |
| 2019 | $19.79M | -27.5% |
| 2018 | $27.30M | -19.4% |
| 2017 | $33.85M | -37.2% |
| 2016 | $53.94M | -25.1% |
| 2015 | $72.04M | +66.7% |
| 2014 | $43.22M | +218.9% |
| 2013 | $13.55M | +201.7% |
| 2012 | $4.49M | +4089.0% |
| 2011 | $107.2K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2022 | $1.11M | -30.7% | -29.6% |
| June 30, 2022 | $1.58M | -21.4% | +12.9% |
| March 31, 2022 | $1.40M | -31.7% | -12.8% |
| September 30, 2021 | $1.60M | -20.8% | -20.2% |
| June 30, 2021 | $2.01M | -26.7% | -1.9% |
| March 31, 2021 | $2.05M | -37.3% | +1.1% |
| September 30, 2020 | $2.03M | -50.3% | -26.1% |
| June 30, 2020 | $2.74M | -44.8% | -16.1% |
- TherapeuticsMD, Inc. showed a decrease of -32.1% in R&D Expense compared to the prior fiscal year.
- Over the 2011–2021 period, TherapeuticsMD, Inc.’s r&d expense has grown by 6507.5% (from $107.2 thousand to $7.09 million).
- The most recent figure is from TherapeuticsMD, Inc.’s fiscal year 2021 report (Form 10-K), filed with the SEC on March 23, 2022.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: